Circulating tumor DNA determining hyperprogressive disease after CAR-T therapy alarms in DLBCL: a case report and literature review

Overview of attention for article published in Frontiers in oncology, November 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 2 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 19,547 followers.

Circulating tumor DNA determining hyperprogressive disease after CAR-T therapy alarms in DLBCL: a case report and literature review https://t.co/8AmSd0Plqb

18 Dec 2023

Reply Repost Favourite

Circulating tumor DNA determining hyperprogressive disease after CAR-T therapy alarms in DLBCL: a case report and literature review https://t.co/8p4NXijewC

17 Dec 2023

Reply Repost Favourite

@uniklinik_hd @uktuebingen @uniklinika

28 Nov 2023

Reply Repost Favourite

RT @FrontOncology: New research: Circulating tumor DNA determining hyperprogressive disease after CAR-T therapy alarms in DLBCL: a case rep…

28 Nov 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.